Literature DB >> 8930034

Lymphangitis carcinomatosa: a literature review.

D M Bruce1, S D Heys, O Eremin.   

Abstract

Intrathoracic metastases occur in 30-40% of patients with malignant disease. In this group 6-8% have lymphangitis carcinomatosa. This review examines the pathogenesis, investigation and treatment of lymphangitis carcinomatosa. The 40-49 years age group is most commonly affected. In 46% of patients respiratory symptoms are the initial presentation of the underlying carcinoma. The most common underlying primary tumours are breast (33%), stomach (29%) and lung cancers (17%). Approximately 50% die within 3 months of their first respiratory symptoms but those with a prostatic primary carcinoma may have good remission with adjuvant hormonal therapy.

Entities:  

Mesh:

Year:  1996        PMID: 8930034

Source DB:  PubMed          Journal:  J R Coll Surg Edinb        ISSN: 0035-8835


  39 in total

1.  Lymphangitis carcinomatosa: report of a case and review of literature.

Authors:  Anand Raja; Ramakrishnan Ayloor Seshadri; Shirley Sundersingh
Journal:  Indian J Surg Oncol       Date:  2011-03-05

2.  Pulmonary lymphangitic carcinomatosis from recurrent gastric cancer 19 years after primary resection: a case report.

Authors:  Sachiko Shioya; Takeshi Masuda; Hiroshi Iwamoto; Kakuhiro Yamaguchi; Shinjiro Sakamoto; Yasushi Horimasu; Shintaro Miyamoto; Taku Nakashima; Kazunori Fujitaka; Hironobu Hamada; Noboru Hattori
Journal:  Clin J Gastroenterol       Date:  2021-01-16

3.  Vascular endothelial growth factor-C induces lymphangitic carcinomatosis, an extremely aggressive form of lung metastases.

Authors:  Suvendu Das; Daniel S Ladell; Simona Podgrabinska; Vladimir Ponomarev; Chandandeep Nagi; John T Fallon; Mihaela Skobe
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

4.  A Rare Case of Progressive Dyspnea and Bilateral Lung Infiltration in a Young Male.

Authors:  Meltem Ağca; Fatma Tokgöz Akyıl; Merve Hörmet; Oğuzhan Akman; Canan Akman; Ayçim Şen; Tülin Sevim
Journal:  Turk Thorac J       Date:  2017-07-01

Review 5.  Role of lymphatic vasculature in regional and distant metastases.

Authors:  Simona Podgrabinska; Mihaela Skobe
Journal:  Microvasc Res       Date:  2014-07-12       Impact factor: 3.514

6.  Dyspnea in palliative care: expanding the role of corticosteroids.

Authors:  Richard J Lin; Ronald D Adelman; Sonal S Mehta
Journal:  J Palliat Med       Date:  2012-03-02       Impact factor: 2.947

7.  Predictors of response to corticosteroids for dyspnea in advanced cancer patients: a preliminary multicenter prospective observational study.

Authors:  Masanori Mori; Akemi Naito Shirado; Tatsuya Morita; Kenichiro Okamoto; Yoshinobu Matsuda; Yoshihisa Matsumoto; Hirohide Yamada; Hiroki Sakurai; Etsuko Aruga; Keisuke Kaneishi; Hiroaki Watanabe; Takashi Yamaguchi; Takuya Odagiri; Shuji Hiramoto; Hiroyuki Kohara; Naoki Matsuo; Hideki Katayama; Tomohiro Nishi; Takashi Matsui; Satoru Iwase
Journal:  Support Care Cancer       Date:  2016-11-29       Impact factor: 3.603

8.  Lymphangitic metastasis of recurrent renal cell carcinoma to the contralateral lung causing lymphangitic carcinomatosis and respiratory symptoms.

Authors:  J B Wallach; T McGarry; J Torres
Journal:  Curr Oncol       Date:  2011-01       Impact factor: 3.677

9.  Pulmonary lymphangitic carcinomatosis as a primary manifestation of colon cancer in a young adult.

Authors:  Anish Thomas; Robert Lenox
Journal:  CMAJ       Date:  2008-08-12       Impact factor: 8.262

10.  Lymphangitis carcinomatosa as an unusual presentation of renal cell carcinoma: a case report.

Authors:  James E Kirk; Maruti Kumaran
Journal:  J Med Case Rep       Date:  2008-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.